Article Details
Retrieved on: 2025-08-08 16:31:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Anti-CD38 monoclonal antibody segment is experiencing the fastest growth in the forecast period due to the success of agents such as daratumumab and ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here